Furthermore, inhibition of BMP3 expression using BMP3-RNAi increases the expression of CCL-2, CCL-3, VCAM-1, MMP-3, and MMP-9 in RA and AIA FLS treated with TNF-α, whereas TIMP-1 expression is decreased. This evidence concerns the gene MMP9 and rheumatoid arthritis.